Clinical Trials Directory

Trials / Completed

CompletedNCT05427799

The Influence of Daily Honey Consumption on IR in Obese Women With IR

The Influence of Daily Honey Consumption on Insulin Resistance in Obese Women With Insulin Resistance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Jordan · Academic / Other
Sex
Female
Age
19 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to evaluate the effects of daily honey consumption on insulin resistance as a preventive measure against diabetes. in women with insulin resistance.

Detailed description

The prevalence rates of insulin resistance (IR) and its health consequences are increasing worldwide. The reputation of honey as a healthy alternative for sugar is largely accepted. Honey contains several bioactive constituents; however, its effect on IR measures and glycemic control is yet to be assessed. We aim to evaluate the effect of daily consumption of honey on IR and inflammatory status measures in obese women with insulin resistance in a free-living controlled intervention study. Sixty obese adult females with insulin resistance will be recruited from the community of the University of Jordan and from patients at the Endocrine unit at the University of Jordan Hospital. Participants will be randomly assigned into one of two treatment groups, honey group or jell-O group. Participants will consume a daily dose of 0.5 mg per kg of body weight of the prescribed treatment for 6 months. The effects of daily consumption of honey on IR, serum concentration of several inflammatory biomarkers, and body fatness will be evaluated. The results of this study would reveal the antidiabetic effect of the bioactive compounds in honey in insulin-resistant obese women.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHoneyA mixed flora honey that will be obtained from local producers. and will be consumed by a daily dose of 0.5 g/kg body weight of honey by each participant and will be divided into two doses.
DIETARY_SUPPLEMENTOther carbohydrate alternatives such as jell-oA daily dose of 0.5 g/kg body weight of Jell-O will be consumed by each participant and will be divided into two doses. Jell-O was selected as a source of sucrose with negligible phenolic capacity.

Timeline

Start date
2022-03-01
Primary completion
2024-05-30
Completion
2024-11-30
First posted
2022-06-22
Last updated
2026-01-27

Locations

2 sites across 1 country: Jordan

Source: ClinicalTrials.gov record NCT05427799. Inclusion in this directory is not an endorsement.